For patients using licensed injectable GLP-1 receptor agonists who have concerns about their treatment, contact your GP or diabetes care team for advice
Brukinsa is also the first BTK inhibitor approved to treat FL
Although the Middle East and Africa market is currently smaller, it is also projected to grow significantly in the coming years 14
Grahams suggestion aligns with the study authors advice, who similarly recommend careful documentation of a patients GLP-1 medication history rather than stopping treatment, to support the accurate interpretation of PET-CT scans while formal national and international guidance is developed.
These research areas are laboratory-focused and should not be interpreted as medical, health, treatment, prevention, cosmetic, skin-related, anti-aging, recovery, performance, or personal-use claims